Identification of peptide superagonists for a self-K-ras-reactive CD4+ T cell clone using combinatorial peptide libraries and mass spectrometry

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7155-7161

  Tanaka, Yoshihiko ^a,b   Ohyama, Hideki ^c   Ogawa, Michio ^b   Nishimura, Yasuharu ^a   Matsushita, Sho ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PEPTIDE LIBRARY;

AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; CELL CLONE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; MASS SPECTROMETRY; ONCOGENE K RAS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PEPTIDES; RAS PROTEINS;

EID: 0033564257     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Evavold, B. D., J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen. 1993. Separation of Th1 clone cylolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
2. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
3. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
4. Matsushita, S., K. Takahashi, M. Motoki, K. Komoriya, S. Ikagawa, and Y. Nishimura. 1994. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 180:873.
5. Chen, Y. Z., S. Matsushita, and Y. Nishimura. 1996. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation. J. Immunol. 157:3783.
6. Yokomizo, H., S. Matsushita, S. Fujisao, S. Murakami, H. Fujita, M. Shirouzu, S. Yokoyama, M. Ogawa, and Y. Nishimura. 1997. Augmentation of immune response by an analog of the antigenic peptide in a human T-cell clone recognizing mutated Ras-derived peptides. Hum. Immunol. 52:22.
7. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K. H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651.
8. Matsushita, S., and T. Matsuoka. 1999. Peptide length-dependent TCR antagonism on class II HLA-restricted responses of peripheral blood mononuclear cells and T cell clones. Eur. J. Immunol. 29:431.
9. + T cell lines reactive with a self-K-ras-derived peptide in vitro, using a mAb to CD29. Hum. Immunol. 59:343.
10. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105.
11. Reinhold, B., and V. Reinhold. 1992. Electrospray ionization mass spectrometry deconvolution by an entropy-based algorithm. J. Am. Soc. Mass Spectrom. 3:207.
12. + T cells specific to streptococcal antigen present in low but not in high responders J. Immunol. 146:2560.
13. Murakami, S., H. Yokomizo, S. Matsushita, M. Ogawa, and Y. Nishimura. 1996 Binding of mutated Ras-and p53-derived peptides to HLA-DR molecules. [Published erratum appears in 1996 Immunol. Lett. 53:61.] Immunol. Lett. 49:149.
14. Vergelli, M., B. Hemmer, M. Kalbus, A. B. Vogt, N. Ling, P. Conlon, J. E. Coligan, H. McFarland, and R. Martin. 1997. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J. Immunol. 158:3746.
15. Hemmer, B., M. Vergelli, B. Gran, N. Ling, P. Conlon, C. Pinilla, R. Houghten, H. F. McFarland, and R. Martin. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160:3631.
16. Kanai, T., Y. Nomura, M. Segawa, K. Takagi, S. Senju, S. Matsushita, and Y. Nishimura. 1997. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor α subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis. Hum. Immunol. 56:28.
17. + T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms. Eur. J. Immunol. 28:305.
18. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants Annu. Rev. Immunol. 11:729.
19. Moudgil, K. D., and E. E. Sercarz. 1994. The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin. Immunol. Immunopathol. 73:283.
20. 37 affects recognition of peptides by T cells. Hum. Immunol. 54:30.
21. Matsushita, S., and Y. Nishimura. 1997. Partial activation of human T cells by peptide analogs on live APC: induction of clonal anergy associated with protein tyrosme dephosphorylation. Hum. Immunol. 53:73.
22. Bos, J. L. 1989. ras oncogenes in human cancer: a review. [Published erratum appears in 1990 Cancer Res. 50:1352.] Cancer Res. 49:4682.
23. Jung, S., and H. J. Schluesener. 1991. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 173:273.
24. ras-derived peptides: characterization of their fine specificity and HLA restriction. Eur. J. Immunol. 23:754.
25. Fossum, B., J. Breivik, G. I. Meling, T. Gedde-Dahl III, T. Hansen, I. Knutsen, T. O. Rognum, E. Thorsby, and G. Gaudernack. 1994. A K-ras 13Gly→Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer: modifying effect of DQ7 on established cancers harbouring this mutation? Int. J. Cancer 58:506.